Form D — KALA BIO, Inc.
0001829126-26-001292 · filed Feb 13, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $4,200,000
- Reported amount sold
- $2,250,600
- Minimum investment
- $44,905
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- KALA BIO, Inc.
- CIK
- 1479419
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1167 MASSACHUSETTS AVENUE
ARLINGTON, MA 02476 - Phone
- 781-996-5252
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
AVI MINKOWITZ · Executive OfficerARLINGTON, MA Find on LinkedIn ↗
-
DAVID LAZAR · DirectorARLINGTON, MA Find on LinkedIn ↗
-
HILLEL POSEN · DirectorARLINGTON, MA Find on LinkedIn ↗
-
CHAIM BERGER · DirectorARLINGTON, MA Find on LinkedIn ↗
-
YONATAN COLMAN · DirectorARLINGTON, MA Find on LinkedIn ↗
-
BRENDAN PURDY · DirectorARLINGTON, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗